Cosmos Health IncNASDAQ:COSMNASDAQ FSI:H. Deficient and Delinquent (Issuer failed to meet continued listing requirements and missed regulatory filing deadline)
- LAST PRICE0.7000
- TODAY'S CHANGE (%)0.0177 (2.5942%)
- Bid / Lots0.6805/ 10
- Ask / Lots0.7159/ 5
- Open / Previous Close0.6830 / 0.6823
- Day Range
- 52 Week Range
- Volume38,387
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | COSM |
|---|---|---|
| 09:32 ET | 1014 | 0.7 |
| 10:15 ET | 150 | 0.7 |
| 10:17 ET | 118 | 0.681 |
| 10:28 ET | 11465 | 0.72 |
| 10:30 ET | 8000 | 0.7025 |
| 10:37 ET | 300 | 0.7199 |
| 11:02 ET | 3300 | 0.715 |
| 11:08 ET | 700 | 0.685 |
| 12:23 ET | 1966 | 0.6937 |
| 12:43 ET | 2000 | 0.69 |
| 12:54 ET | 200 | 0.69 |
| 12:56 ET | 795 | 0.69 |
| 01:12 ET | 3099 | 0.69 |
| 01:30 ET | 700 | 0.69 |
| 01:37 ET | 300 | 0.69 |
| 03:21 ET | 360 | 0.699999 |
| 03:50 ET | 116 | 0.69 |
| 03:54 ET | 200 | 0.7 |
May 17, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cosmos Health Inc | 11.6M | -0.1x | --- |
Progressive Care Inc | 12.9M | -0.6x | --- |
Medical Marijuana Inc | 9.8M | 0.0x | --- |
SunLink Health Systems Inc | 4.2M | -1.4x | --- |
HealthWarehouse.com Inc | 7.1M | -3.5x | --- |
ZEO ScientifiX Inc | 6.7M | -1.3x | --- |
Company Information
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
Contact Information
- Headquarters
- 141 W. JACKSON BLVD, SUITE 4236CHICAGO, IL, United States 60604
- Phone
- 312-536-3102
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Grigorios Siokas
- Chief Financial Officer
- Georgios Terzis
- Chief Operating Officer
- Nikos Bardakis
- Independent Director
- Anastasios Aslidis
- Independent Director
- Suhel Bhutawala
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.6M |
|---|---|
Revenue (TTM) | $49.6M |
Shares Outstanding | 16.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.00 |
EPS | $-7.92 |
Book Value | $3.74 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -24.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
